In 2021, the market for Infant Oxygen Hood worldwide was worth $ 12.5 million US dollars. AMR Group projects that the market will reach US$ 31 billion by 2031, growing at a CAGR of 9.5 percent between 2022 and 2031.

Industry Overview
Infant Oxygen Hoods are medical devices designed to provide newborns with oxygen therapy for the respiratory issues. Oxygen is used as an essential drug for the treatment & prevention of neonatal hypoxia. However, the excessive usage of oxygen can lead to long-lasting & serious anomalies. These devices are basically used in the treatment of premature infants and those babies born with congenital respiratory disorders. Oxygen hoods are connected to the oxygen source with the input of a hose or a tube. Oxygen hoods are a kind of delivery hoods, which consist of a transparent plastic shell that encloses an infant’s head. Oxygen hoods are typically placed on a neck ring, which provides them to grip a gas-tight seal. Oxygen hoods may include humidity, temperature, and oxygen concentration sensors. They may also include supply & exhaust ports for gas tube connections. Medical devices, like neonatal oxygen hood, oxygen hood for infants, and oxygen hood for newborns, are essential devices in neonatal care. As these provide precise flow of oxygen to the infant, helping to manage respiratory issues and improve overall health. These devices are designed to fit over an infant's head to provide a flow of oxygen to help breathe normally and easily. They are typically made from materials like acrylic glass or polycarbonate, as they are firm, durable, and easy to sterilize. These devices are used in different medical procedures, with the treatment of respiratory distress in newborns and the management of respiratory issues in premature infants. These devices are also used in digital neonatal care, which involves the usage of advanced technologies to monitor and treat respiratory problems in newborns.

Market Dynamics
In Infant Oxygen Hood Market there is an increase in incidences of respiratory disorders among newborns is a major factor driving the global infant oxygen hoods market. As respiratory problems are common in newborns, particularly premature infants and those born with congenital respiratory issues. These issues could be ranged from mild to severe, and require different forms of treatment, which includes oxygen therapy. According to the World Health Organization (WHO) in 2019, respiratory problems are the leading cause of morbidity and mortality in infants and babies, particularly in developing economical countries. The report estimates that approximately 16% of neonatal deaths globally were due to respiratory issues.

Technological advancements are driving the infant oxygen hoods market by providing the development of more advanced devices that incorporate advanced technologies & materials. These advancements gave a higher effectiveness and safety of infant oxygen hoods. High Demand for Lightweight, Transparent Devices and Shatter-resistant. This can be ascribed to technological advancements, advantages, and rise in launching of new products. Furthermore, high treatment cost is a factor that is likely to hamper the growth of the Infant Oxygen Hood which may restrain the market growth.

COVID Impact
The COVID-19 pandemic has had a negative impact on the business. Outbreak of the virus and the simultaneous lockdowns and restrictions on non-essential businesses led to a direct decline in demand for infant oxygen hoods. Hospitals & neonatal care facilities were restricted to reduce the capacity or shut down completely, leading to a decrease in infant oxygen hoods market demand. This was further aggravated by the decrease in the number of medical procedures performed due to the pandemic. Many procedures that require the usage of Oxygen hood devices were postponed or canceled due to the pandemic which led to a decrease in demand for these devices. However, demand for these devices has been recovering after the resolving restrictions. Hospitals & neonatal care facilities have started to re-open, and the demand for medical procedures has simultaneously increased. Similarly, demand for infant oxygen hoods is also expected to recover in the upcoming years.

Regional Trend
Geographically, North America dominated the Infant Oxygen Hood market and had the largest revenue share in 2021. The growth in this region can be attributed to due to high incidence of premature births and availability of advanced medical facilities. However, High incidence of premature birth has led to a rise in demand for infant oxygen hoods and other neonatal care products. Availability of advanced medical facilities has also contributed to the increase in infant oxygen hoods industry revenue in North America. According to WHO (World Health Organization), the preterm birth rate in the U.S. is around 10.1%, which is one of the highest in the world. Preterm birth is found to be a major cause of respiratory distress in newborns.

Asia Pacific region is expected to present outstanding infant oxygen hoods market opportunities due to the increasing demand for advanced medical devices. Also rising awareness about the importance of neonatal care in the region. Huge investments in healthcare infrastructure and acceptance of advanced medical technologies in China and India have increased in specialized neonatal care facilities. Rise in awareness among parents about the potential long-term effects of respiratory distress in newborns has enhanced the emphasis on early diagnosis & treatment. This has led to increase in the number of premature and critically ill infants treated in NICUs in Asia Pacific which enhances its growth potential.

Competitive Landscape
Key players operating in the Infant Oxygen Hood Market include Dräger, Fanem Ltd., GaleMed Corporation, GE Healthcare, GINEVRI SRL, Jørgen Kruuse A/S, Jorgensen Labs., Meter Co., Ltd., Natus Medical Incorporated, nice Neötech Medical Systems Pvt. Ltd., Ningbo David Medical Device Co., Ltd., Olidef Medical, Phoenix Medical Systems (P) Ltd., Plasti-med Medikal Ürünler San. Tic. Ltd., S S Technomed (P) Ltd., Utah Medical Products, Inc., and Zhengzhou Dison Instrument among others. In August 2019, Dräger introduced the Babylog VN500 neonatal ventilator in Germany. This device features a range of advanced technologies designed to help healthcare professionals accurately and safely treat infants with respiratory distress.

Key USP’s-
In 2019, GE Healthcare announced the acquisition of Novalung, a Germany-based manufacturer of extracorporeal oxygenation (ECMO) systems, including infant oxygen hoods. The acquisition boosted GE Healthcare to build its presence in the ECMO market and key to access Novalung's advanced technology in this area.

Market Segmentation
Based upon the Material used in the Infant Oxygen Hood market is segmented in Acrylic Glass and Polycarbonate. The polycarbonate material dominated the infant oxygen hoods market in 2021. Polycarbonate is a strong and durable material, proving it suitable for usage in oxygen hoods. It is lightweight, transparent, shatter-resistant and easy to sterilize & maintain compared to other materials. Based on the usage, the Infant Oxygen Hood market is segmented into Disposable Hoods and Reusable Hoods. In the usage segment the most dominant market is reusable hoods which covered the largest infant oxygen hoods market share in 2021. This segment is driven by cost-effectiveness devices and environmental safety.

End user segment of Infant Oxygen Hood market is further bifurcated into Hospitals & Clinics and Research & Academic Institutes. The hospitals & clinics segment held major share of the global market in 2021. Demand for medical equipment, including infant oxygen hoods, is high in hospitals & clinics due to the rising number of patients visiting for treatment.

By Material
• Acrylic Glass
• Polycarbonate

By Usage
• Disposable Hoods
• Reusable Hoods

By End User
• Hospitals & Clinics
• Research & Academic Institutes